ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma

Yuan, Ying-Shi; Jin, Xin; Chen, Lu; Liao, Jia-Min; Zhang, Yang; Yu, Ke-Wei; Li, Wei-Kang; Cao, Shun-Wang; Huang, Xian-Zhang*; Kang, Chun-Min*广东省人民医院; 广州中医药大学
Frontiers in Immunology2022-10-25DOI: 10.3389/fimmu.2022.1027794
2被引9阅读
引用收藏
分享

摘要

BackgroundGlioma is a highly aggressive brain cancer with a poor prognosis. Necroptosis is a form of programmed cell death occurring during tumor development and in immune microenvironments. The prognostic value of necroptosis in glioma is unclear. This study aimed to develop a prognostic glioma model based on necroptosis. MethodsA necroptosis-related risk model was constructed by Cox regression analysis based on The Cancer Genome Atlas (TCGA) training set, validated in two Chinese Glioma Genome Atlas (CGGA) validation sets. We explored the differences in immune infiltration and immune checkpoint genes between low and high risk groups and constructed a nomogram. Moreover, we compiled a third validation cohort including 43 glioma patients. The expression of necroptosis-related genes was verified in matched tissues using immunochemical staining in the third cohort, and we analyzed their relationship to clinicopathological features. ResultsThree necroptosis-related differentially expressed genes (EZH2, LEF1, and CASP1) were selected to construct the prognostic model. Glioma patients with a high risk score in the TCGA and CGGA cohorts had significantly shorter overall survival. The necroptosis-related risk model and nomogram exhibited good predictive performance in the TCGA training set and the CGGA validation sets. Furthermore, patients in the high risk group had higher immune infiltration status and higher expression of immune checkpoint genes, which was positively correlated with poorer outcomes. In the third validation cohort, the expression levels of the three proteins encoded by EZH2, LEF1, and CASP1 in glioma tissues were significantly higher than those from paracancerous tissues. They were also closely associated with disease severity and prognosis. ConclusionsOur necroptosis-related risk model can be used to predict the prognosis of glioma patients and improve prognostic accuracy, which may provide potential therapeutic targets and a theoretical basis for treatment.

学科与关键词

关键词
gliomanecroptosisprognostic modelimmune infiltrationimmune checkpoint
相关
加载中…
  • Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patients
    Chen, Desheng; Dou, Chao; Liu, Haiyu; Xu, Binshun; Hu, Bowen; Kuang, Liangwen; Yao, Jiawei; Zhao, Yan; Yu, Shan; Li, Yang; Wang, Fuqing*; Guo, Mian*Frontiers in Oncology, 2022, 12: 929233.被引 4
  • A Pyroptosis-Related Gene Signature for Predicting Survival in Glioblastoma.
    Li, Xin-Yu; Zhang, Lu-Yu; Li, Xue-Yuan; Yang, Xi-Tao; Su, Li-XinFrontiers in Oncology, 2021, 11: 697198.
  • Identification of Necroptosis-related Molecular Subtypes and Construction of Necroptosis-related Gene Signature for Glioblastoma Multiforme
    Li, Zhiyong; Jin, Yinghui; Que, Tianshi; Zhang, Xi-an; Yi, Guozhong; Zheng, Haojie; Yuan, Xi; Wang, Xiaoyan; Xu, Haiyan; Nan, Jing; Chen, Chao; Wu, Yuankui*; Huang, Guanglong*Current Medicinal Chemistry, 2023.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-10-25
卷期
第 13 卷
页码
1027794
DOI
10.3389/fimmu.2022.1027794
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Sciences Foundation of China [82072336]; Natural Science Fund of Guangdong [2019A1515010178, 2019B1515120004, 2021A1515111125]; Science and Technology Program of Guangzhou [202002020038, 202102010173, 202103000025]; Guangdong basic and Applied Basic Research Foundation project-key project of Regional Joint Fund [2019B1515120004]; Dongguan Science and Technology of Social Development Program [201950715023190]; Guangzhou Basic and Applied Basic Research project [202102020101]; China Postdoctoral Science Foundation [2021M700904]; Project of Administration of Traditional Chinese Medicine of Guangdong Province of China [20211180, 20202067]

作者

  • Y

    Yuan, Ying-Shi (第一作者)

    guangdong prov hosp · 2 · guangzhou univ chinese med

  • J

    Jin, Xin

查看全部 10 位作者收起作者
  • C

    Chen, Lu

    2 · guangzhou univ chinese med

  • L

    Liao, Jia-Min

    2 · guangzhou univ chinese med

  • Z

    Zhang, Yang

    2 · guangzhou univ chinese med

  • Y

    Yu, Ke-Wei

    2 · guangzhou univ chinese med

  • L

    Li, Wei-Kang

    2 · guangzhou univ chinese med

  • C

    Cao, Shun-Wang

    2 · guangzhou univ chinese med

  • H

    Huang, Xian-Zhang (通讯)

    guangdong prov hosp · 2 · guangzhou univ chinese med

  • K

    Kang, Chun-Min (通讯)

    guangdong prov hosp · 2 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417